Aggrenox

Product NDC: 0597-0001
11-digit product format: 005970001
Labeler code: 0597
Product ID: 0597-0001_afbcb310-8722-47df-acac-c5fcb2c4bb2f
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: aspirin and dipyridamole
Dosage form: CAPSULE, EXTENDED RELEASE
Route: ORAL
Labeler: Boehringer Ingelheim Pharmaceuticals Inc.
Application: NDA020884
Marketing category: NDA
Marketing start: 1999-12-19
Marketing end: 0000-00-00
Substance: ASPIRIN; DIPYRIDAMOLE
Active strength: 25 mg/1; mg/1
Pharmacologic classes: Platelet Aggregation Inhibitor [EPC],Decreased Platelet Aggregation [PE],Cyclooxygenase Inhibitors [MoA],Decreased Prostaglandin Production [PE],Anti-Inflammatory Agents, Non-Steroidal [CS],Nonsteroidal Anti-inflammatory Drug [EPC],Decreased Platelet Aggregation [PE],Platelet Aggregation Inhibitor [EPC]
NDC exclude flag: No
Listing certified through: 2022-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

Explicit status records from FDA unfinished, excluded, and compounder auxiliary files. Absence of a row is not itself a regulatory status. Browse every current auxiliary row, including rows without a usable NDC. · Browse every captured source and parsed snapshot.

Current NDC status page 1 of 1 · 3 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Source date
excluded product	product	0597-0001		D	Discontinued by firm	2026-08-03
excluded package	package	0597-0001	0597-0001-11	D	Discontinued by firm	2026-08-03
excluded package	package	0597-0001	0597-0001-60	D	Discontinued by firm	2026-08-03

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
N020884-001	AGGRENOX	ASPIRIN; DIPYRIDAMOLE	25MG;200MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	CAPSULE, EXTENDED RELEASE / ORAL		RLD	1999-11-22

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 41 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	RLD / RS	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	N020884-001	AGGRENOX	25MG;200MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	CAPSULE, EXTENDED RELEASE / ORAL		RLD	1999-11-22	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N020884-001	AGGRENOX	25MG;200MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	CAPSULE, EXTENDED RELEASE / ORAL		RLD	1999-11-22	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N020884-001	AGGRENOX	25MG;200MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	CAPSULE, EXTENDED RELEASE / ORAL		RLD	1999-11-22	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N020884-001	AGGRENOX	25MG;200MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	CAPSULE, EXTENDED RELEASE / ORAL		RLD	1999-11-22	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N020884-001	AGGRENOX	25MG;200MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	CAPSULE, EXTENDED RELEASE / ORAL		RLD	1999-11-22	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N020884-001	AGGRENOX	25MG;200MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	CAPSULE, EXTENDED RELEASE / ORAL		RLD	1999-11-22	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N020884-001	AGGRENOX	25MG;200MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	CAPSULE, EXTENDED RELEASE / ORAL		RLD	1999-11-22	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N020884-001	AGGRENOX	25MG;200MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	CAPSULE, EXTENDED RELEASE / ORAL		RLD	1999-11-22	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N020884-001	AGGRENOX	25MG;200MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	CAPSULE, EXTENDED RELEASE / ORAL		RLD	1999-11-22	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N020884-001	AGGRENOX	25MG;200MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	CAPSULE, EXTENDED RELEASE / ORAL		RLD	1999-11-22	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N020884-001	AGGRENOX	25MG;200MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	CAPSULE, EXTENDED RELEASE / ORAL		RLD	1999-11-22	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N020884-001	AGGRENOX	25MG;200MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	CAPSULE, EXTENDED RELEASE / ORAL		RLD	1999-11-22	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N020884-001	AGGRENOX	25MG;200MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	CAPSULE, EXTENDED RELEASE / ORAL		RLD	1999-11-22	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N020884-001	AGGRENOX	25MG;200MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	CAPSULE, EXTENDED RELEASE / ORAL		RLD	1999-11-22	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N020884-001	AGGRENOX	25MG;200MG	CAPSULE, EXTENDED RELEASE / ORAL	AB	RLD, RS	1999-11-22	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N020884-001	AGGRENOX	25MG;200MG	CAPSULE, EXTENDED RELEASE / ORAL	AB	RLD, RS	1999-11-22	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N020884-001	AGGRENOX	25MG;200MG	CAPSULE, EXTENDED RELEASE / ORAL	AB	RLD, RS	1999-11-22	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N020884-001	AGGRENOX	25MG;200MG	CAPSULE, EXTENDED RELEASE / ORAL	AB	RLD, RS	1999-11-22	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	N020884-001	AGGRENOX	25MG;200MG	CAPSULE, EXTENDED RELEASE / ORAL	AB	RLD, RS	1999-11-22	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	N020884-001	AGGRENOX	25MG;200MG	CAPSULE, EXTENDED RELEASE / ORAL	AB	RLD, RS	1999-11-22	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N020884-001	AGGRENOX	25MG;200MG	CAPSULE, EXTENDED RELEASE / ORAL	AB	RLD, RS	1999-11-22	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	N020884-001	AGGRENOX	25MG;200MG	CAPSULE, EXTENDED RELEASE / ORAL	AB	RLD, RS	1999-11-22	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	N020884-001	AGGRENOX	25MG;200MG	CAPSULE, EXTENDED RELEASE / ORAL	AB	RLD, RS	1999-11-22	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	N020884-001	AGGRENOX	25MG;200MG	CAPSULE, EXTENDED RELEASE / ORAL	AB	RLD, RS	1999-11-22	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	N020884-001	AGGRENOX	25MG;200MG	CAPSULE, EXTENDED RELEASE / ORAL	AB	RLD, RS	1999-11-22	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	N020884-001	AGGRENOX	25MG;200MG	CAPSULE, EXTENDED RELEASE / ORAL	AB	RLD, RS	1999-11-22	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	N020884-001	AGGRENOX	25MG;200MG	CAPSULE, EXTENDED RELEASE / ORAL	AB	RLD, RS	1999-11-22	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	N020884-001	AGGRENOX	25MG;200MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	CAPSULE, EXTENDED RELEASE / ORAL		RLD	1999-11-22	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	N020884-001	AGGRENOX	25MG;200MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	CAPSULE, EXTENDED RELEASE / ORAL		RLD	1999-11-22	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	N020884-001	AGGRENOX	25MG;200MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	CAPSULE, EXTENDED RELEASE / ORAL		RLD	1999-11-22	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	N020884-001	AGGRENOX	25MG;200MG	CAPSULE, EXTENDED RELEASE / ORAL		RLD	1999-11-22	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	N020884-001	AGGRENOX	25MG;200MG	CAPSULE, EXTENDED RELEASE / ORAL		RLD	1999-11-22	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	N020884-001	AGGRENOX	25MG;200MG	CAPSULE, EXTENDED RELEASE / ORAL		RLD	1999-11-22	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	N020884-001	AGGRENOX	25MG;200MG	CAPSULE, EXTENDED RELEASE / ORAL		RLD	1999-11-22	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	N020884-001	AGGRENOX	25MG;200MG	CAPSULE, EXTENDED RELEASE / ORAL		RLD	1999-11-22	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	N020884-001	AGGRENOX	25MG;200MG	CAPSULE, EXTENDED RELEASE / ORAL		RLD	1999-11-22	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	N020884-001	AGGRENOX	25MG;200MG	CAPSULE, EXTENDED RELEASE / ORAL		RLD	1999-11-22	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	N020884-001	AGGRENOX	25MG;200MG	CAPSULE, EXTENDED RELEASE / ORAL	AB	RLD, RS	1999-11-22	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	N020884-001	AGGRENOX	25MG;200MG	CAPSULE, EXTENDED RELEASE / ORAL	AB	RLD, RS	1999-11-22	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	N020884-001	AGGRENOX	25MG;200MG	CAPSULE, EXTENDED RELEASE / ORAL	AB	RLD, RS	1999-11-22	`cb3db0bc1861…`

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N020884-001	AB	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N020884-001	AB	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N020884-001	AB	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N020884-001	AB	1	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	N020884-001	AB	1	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	N020884-001	AB	1	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N020884-001	AB	1	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	N020884-001	AB	1	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	N020884-001	AB	1	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	N020884-001	AB	1	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	N020884-001	AB	1	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	N020884-001	AB	1	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	N020884-001	AB	1	`ea99ee380514…`
2022-10-28 04:53 UTC	2022-10	N020884-001	AB	1	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	N020884-001	AB	1	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	N020884-001	AB	1	`cb3db0bc1861…`

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
d7724692-1155-4cc8-a415-22f5fc4aec35	Product name	6	20220216
bde672ba-4805-28d0-1986-73543d41b412	Product name	2	20210201
f52be47f-7aa7-46c0-b1fa-50c18dd50206	Product name	1	20201029
f212291f-05fe-9603-fc7e-bd73e38ce1e6	Product name	2	20161129
ade821ba-260a-47e2-bd89-743e27ac9906	Product name	1	20161121
182f9ab4-4ab5-c449-200f-87ce2ce8e550	Product name	2	20151105
9425d234-4ae1-4b53-adc6-8cc7af6dd657	Product name	1	20150929
2a21311a-89e2-0e83-2ebd-117f9798b2b2	Product name	1	20140508
3285f096-1048-1647-9b36-a2e0f5b56c6c	Product name	1	20140508
9007e8a7-ff50-f9b9-7945-f2a1deadd94e	Product name	1	20140508
96c2be53-8e44-452d-56a2-d255b2f1af2d	Product name	1	20140508
9ab2f788-fb50-9b8e-e14c-49841b1b5968	Product name	1	20140508
bf8bd5f7-495f-4022-2780-7ded7ea7ea44	Product name	1	20140508

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
0597-0001-60	EA - Each	0597-0001	29373277-52cb-4af8-b604-4676b6a47cc9	1	2012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
aspirin	ACTIVE INGREDIENT	R16CO5Y76E	AGGRENOX (ASPIRIN AND DIPYRIDAMOLE) CAPSULE [BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.]	13
dipyridamole	ACTIVE INGREDIENT	64ALC7F90C	AGGRENOX (ASPIRIN AND DIPYRIDAMOLE) CAPSULE [BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.]	13
aspirin	ACTIVE MOIETY	R16CO5Y76E	AGGRENOX (ASPIRIN AND DIPYRIDAMOLE) CAPSULE [BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.]	13
dipyridamole	ACTIVE MOIETY	64ALC7F90C	AGGRENOX (ASPIRIN AND DIPYRIDAMOLE) CAPSULE [BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.]	13
aspirin	ACTIVE INGREDIENT	R16CO5Y76E	AGGRENOX (ASPIRIN AND DIPYRIDAMOLE) CAPSULE [CARILION MATERIALS MANAGEMENT]	2
aspirin	ACTIVE INGREDIENT	R16CO5Y76E	AGGRENOX (ASPIRIN AND DIPYRIDAMOLE) CAPSULE [PHYSICIANS TOTAL CARE, INC.]	2
dipyridamole	ACTIVE INGREDIENT	64ALC7F90C	AGGRENOX (ASPIRIN AND DIPYRIDAMOLE) CAPSULE [CARILION MATERIALS MANAGEMENT]	2
dipyridamole	ACTIVE INGREDIENT	64ALC7F90C	AGGRENOX (ASPIRIN AND DIPYRIDAMOLE) CAPSULE [PHYSICIANS TOTAL CARE, INC.]	2
aspirin	ACTIVE MOIETY	R16CO5Y76E	AGGRENOX (ASPIRIN AND DIPYRIDAMOLE) CAPSULE [CARILION MATERIALS MANAGEMENT]	2
aspirin	ACTIVE MOIETY	R16CO5Y76E	AGGRENOX (ASPIRIN AND DIPYRIDAMOLE) CAPSULE [PHYSICIANS TOTAL CARE, INC.]	2
dipyridamole	ACTIVE MOIETY	64ALC7F90C	AGGRENOX (ASPIRIN AND DIPYRIDAMOLE) CAPSULE [CARILION MATERIALS MANAGEMENT]	2
dipyridamole	ACTIVE MOIETY	64ALC7F90C	AGGRENOX (ASPIRIN AND DIPYRIDAMOLE) CAPSULE [PHYSICIANS TOTAL CARE, INC.]	2
ACACIA	INACTIVE INGREDIENT	5C5403N26O	AGGRENOX (ASPIRIN AND DIPYRIDAMOLE) CAPSULE [PHYSICIANS TOTAL CARE, INC.]	2
ALUMINUM STEARATE	INACTIVE INGREDIENT	U6XF9NP8HM	AGGRENOX (ASPIRIN AND DIPYRIDAMOLE) CAPSULE [PHYSICIANS TOTAL CARE, INC.]	2
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	AGGRENOX (ASPIRIN AND DIPYRIDAMOLE) CAPSULE [PHYSICIANS TOTAL CARE, INC.]	2
DIMETHICONE	INACTIVE INGREDIENT	92RU3N3Y1O	AGGRENOX (ASPIRIN AND DIPYRIDAMOLE) CAPSULE [PHYSICIANS TOTAL CARE, INC.]	2
FERRIC OXIDE RED	INACTIVE INGREDIENT	1K09F3G675	AGGRENOX (ASPIRIN AND DIPYRIDAMOLE) CAPSULE [PHYSICIANS TOTAL CARE, INC.]	2
FERRIC OXIDE YELLOW	INACTIVE INGREDIENT	EX438O2MRT	AGGRENOX (ASPIRIN AND DIPYRIDAMOLE) CAPSULE [PHYSICIANS TOTAL CARE, INC.]	2
GELATIN	INACTIVE INGREDIENT	2G86QN327L	AGGRENOX (ASPIRIN AND DIPYRIDAMOLE) CAPSULE [PHYSICIANS TOTAL CARE, INC.]	2
hypromellose phthalate (31% phthalate, 170 cst)	INACTIVE INGREDIENT	8LDD2V82F5	AGGRENOX (ASPIRIN AND DIPYRIDAMOLE) CAPSULE [PHYSICIANS TOTAL CARE, INC.]	2
HYPROMELLOSES	INACTIVE INGREDIENT	3NXW29V3WO	AGGRENOX (ASPIRIN AND DIPYRIDAMOLE) CAPSULE [PHYSICIANS TOTAL CARE, INC.]	2
LACTOSE MONOHYDRATE	INACTIVE INGREDIENT	EWQ57Q8I5X	AGGRENOX (ASPIRIN AND DIPYRIDAMOLE) CAPSULE [PHYSICIANS TOTAL CARE, INC.]	2
methacrylic acid - methyl methacrylate copolymer (1:1)	INACTIVE INGREDIENT	74G4R6TH13	AGGRENOX (ASPIRIN AND DIPYRIDAMOLE) CAPSULE [PHYSICIANS TOTAL CARE, INC.]	2
POVIDONE	INACTIVE INGREDIENT	FZ989GH94E	AGGRENOX (ASPIRIN AND DIPYRIDAMOLE) CAPSULE [PHYSICIANS TOTAL CARE, INC.]	2
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	AGGRENOX (ASPIRIN AND DIPYRIDAMOLE) CAPSULE [PHYSICIANS TOTAL CARE, INC.]	2
STARCH, CORN	INACTIVE INGREDIENT	O8232NY3SJ	AGGRENOX (ASPIRIN AND DIPYRIDAMOLE) CAPSULE [PHYSICIANS TOTAL CARE, INC.]	2
STEARIC ACID	INACTIVE INGREDIENT	4ELV7Z65AP	AGGRENOX (ASPIRIN AND DIPYRIDAMOLE) CAPSULE [PHYSICIANS TOTAL CARE, INC.]	2
SUCROSE	INACTIVE INGREDIENT	C151H8M554	AGGRENOX (ASPIRIN AND DIPYRIDAMOLE) CAPSULE [PHYSICIANS TOTAL CARE, INC.]	2
TALC	INACTIVE INGREDIENT	7SEV7J4R1U	AGGRENOX (ASPIRIN AND DIPYRIDAMOLE) CAPSULE [PHYSICIANS TOTAL CARE, INC.]	2
TARTARIC ACID	INACTIVE INGREDIENT	W4888I119H	AGGRENOX (ASPIRIN AND DIPYRIDAMOLE) CAPSULE [PHYSICIANS TOTAL CARE, INC.]	2
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	AGGRENOX (ASPIRIN AND DIPYRIDAMOLE) CAPSULE [PHYSICIANS TOTAL CARE, INC.]	2
TRIACETIN	INACTIVE INGREDIENT	XHX3C3X673	AGGRENOX (ASPIRIN AND DIPYRIDAMOLE) CAPSULE [PHYSICIANS TOTAL CARE, INC.]	2
WATER	INACTIVE INGREDIENT	059QF0KO0R	AGGRENOX (ASPIRIN AND DIPYRIDAMOLE) CAPSULE [PHYSICIANS TOTAL CARE, INC.]	2

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
R16CO5Y76E	ASPIRIN	50-78-2	ASPIRIN
64ALC7F90C	DIPYRIDAMOLE	58-32-2	DIPYRIDAMOLE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
1362082	Aggrenox 25 MG / 200 MG 12HR Extended Release Oral Capsule	PSN	f07c8535-f9fb-4697-9b63-1ab22210efc9	3
259081	aspirin 25 MG / dipyridamole 200 MG 12HR Extended Release Oral Capsule	PSN	f07c8535-f9fb-4697-9b63-1ab22210efc9	3
1362082	12 HR aspirin 25 MG / dipyridamole 200 MG Extended Release Oral Capsule [Aggrenox]	SBD	f07c8535-f9fb-4697-9b63-1ab22210efc9	3
259081	12 HR aspirin 25 MG / dipyridamole 200 MG Extended Release Oral Capsule	SCD	f07c8535-f9fb-4697-9b63-1ab22210efc9	3
259081	12 HR ASA 25 MG / Dipyridamole 200 MG Extended Release Oral Capsule	SY	f07c8535-f9fb-4697-9b63-1ab22210efc9	3
1362082	12 HR ASA 25 MG / Dipyridamole 200 MG Extended Release Oral Capsule [Aggrenox]	SY	f07c8535-f9fb-4697-9b63-1ab22210efc9	3
1362082	Aggrenox 25/200 (aspirin 25 MG / dipyridamole 200 MG) 12HR Extended Release Oral Capsule	SY	f07c8535-f9fb-4697-9b63-1ab22210efc9	3
1362082	Aggrenox 25/200 12HR Extended Release Oral Capsule	SY	f07c8535-f9fb-4697-9b63-1ab22210efc9	3
259081	aspirin 25 MG / dipyridamole 200 MG 12HR Extended Release Oral Capsule	SY	f07c8535-f9fb-4697-9b63-1ab22210efc9	3
1362082	Aggrenox 25 MG / 200 MG 12HR Extended Release Oral Capsule	PSN	e729d829-4bd0-4074-85ea-e0f9f5d7cdb5	2
259081	aspirin 25 MG / dipyridamole 200 MG 12HR Extended Release Oral Capsule	PSN	e729d829-4bd0-4074-85ea-e0f9f5d7cdb5	2
1362082	12 HR aspirin 25 MG / dipyridamole 200 MG Extended Release Oral Capsule [Aggrenox]	SBD	e729d829-4bd0-4074-85ea-e0f9f5d7cdb5	2
259081	12 HR aspirin 25 MG / dipyridamole 200 MG Extended Release Oral Capsule	SCD	e729d829-4bd0-4074-85ea-e0f9f5d7cdb5	2
259081	12 HR ASA 25 MG / Dipyridamole 200 MG Extended Release Oral Capsule	SY	e729d829-4bd0-4074-85ea-e0f9f5d7cdb5	2
1362082	12 HR ASA 25 MG / Dipyridamole 200 MG Extended Release Oral Capsule [Aggrenox]	SY	e729d829-4bd0-4074-85ea-e0f9f5d7cdb5	2
1362082	Aggrenox 25/200 (aspirin 25 MG / dipyridamole 200 MG) 12HR Extended Release Oral Capsule	SY	e729d829-4bd0-4074-85ea-e0f9f5d7cdb5	2
1362082	Aggrenox 25/200 12HR Extended Release Oral Capsule	SY	e729d829-4bd0-4074-85ea-e0f9f5d7cdb5	2
259081	aspirin 25 MG / dipyridamole 200 MG 12HR Extended Release Oral Capsule	SY	e729d829-4bd0-4074-85ea-e0f9f5d7cdb5	2

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
0597-0001-60	00597000160	1 BOTTLE in 1 CARTON (0597-0001-60) > 60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE	1 bottle	1999-12-19	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Aggrenox	Boehringer Ingelheim Pharmaceuticals Inc. \| Boehringer Ingelheim Pharmaceuticals, Inc. \| Polpharma S.A. \| Malgrat Pharma Chemicals, S.L.U. \| Boehringer Ingelheim Pharma GmbH and Co. KG	2021-05-21	HUMAN PRESCRIPTION DRUG LABEL	20
Aggrenox	Carilion Materials Management	2016-08-06	HUMAN PRESCRIPTION DRUG LABEL	3
Aggrenox	Physicians Total Care, Inc.	2012-04-16	HUMAN PRESCRIPTION DRUG LABEL	2